Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Greenleaf Insider Profile
4 Followers
Peter Greenleaf, CEO at Sucampo Pharmaceuticals, holds 0.00 shares in Sucampo Pharmaceuticals (Ticker: SCMP), holds ― shares in Synlogic (Ticker: SYBX), holds ― shares in Cerecor Inc (Ticker: CERCU).
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+20.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter Greenleaf holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter Greenleaf
Peter Greenleaf's Trading History
Sucampo Pharmaceuticals
Feb 13, 2018
―
Uninformative Sell
2.34M
$0.00
Synlogic
―
Director
―
―
Cerecor Inc
―
Director
―
―
Avalo Therapeutics
May 29, 2019
Director
Uninformative Sell
―
$1.46M
BioDelivery
Mar 22, 2022
―
Uninformative Sell
―
$0.00
Kiora Pharmaceuticals
―
Director
―
―
Antares Pharma
Jun 14, 2021
―
Uninformative Buy
112.50K
$445.22K
Aurinia Pharmaceuticals
Mar 07, 2024
CEO, Director
Informative Sell
711.09K
$7.75M
List of latest transactions for each holding click on a transaction to see Peter Greenleaf's performance on stock
You May Also Like
Peter Greenleaf insider profile FAQ
What is the percentage of profitable transactions made by Peter Greenleaf?
The percentage of profitable transactions made by Peter Greenleaf is 83%.
What is the average return per transaction made by Peter Greenleaf?
The average return per transaction made by Peter Greenleaf is 20.00%.
What stocks does Peter Greenleaf hold?
Peter Greenleaf holds: SCMP, SYBX, CERCU, AVTX, BDSI, KPRX, ATRS, AUPH stocks.
What was Peter Greenleaf’s latest transaction?
Peter Greenleaf latest transaction was an Uninformative Sell of $2.34M.
What was Peter Greenleaf's most profitable transaction?
Peter Greenleaf’s most profitable transaction was an Informative Buy of AVTX stock on May 21, 2018. The return on the trade was 41.30%.
What is Peter Greenleaf's role in Sucampo Pharmaceuticals?
Peter Greenleaf's role in Sucampo Pharmaceuticals is CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.